MEK-inhibitor (inh) and hydroxychloroquine (HCQ) in KRAS-mutated advanced pancreatic ductal adenocarcinoma (PDAC). Journal of Clinical Oncology Journal of Clinical Oncology 40, no. 16_suppl (June 01, 2022) e16260-e16260
Date
06/02/2022Author List
Mehdi M, Thalij SZ, Shreenivas AV, Chakrabarti S, Thomas JP, Christians KK, Evans DB, Hall WA, Erickson B, Thapa B, Ahmad G, Yazdanpanah O, Kurzrock R, Aldakkak M, Holden MB, George B, Tsai S, Oxencis C, McFall T, Kamgar MAuthor
Mandana Kamgar MD Assistant Professor in the Medicine department at Medical College of WisconsinView Online